| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Scribe Therapeutics Inc. (SCTX) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. SCTX is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.09M | $73.52M | +2.39M | |
| 10% | 2.05M | $48.83M | +333.3K | |
| Dir | 348.8K | $8.30M | +1.00M | |
| CEO | 264.8K | $6.30M | - | |
| CFO | 109.4K | $2.60M | +2.7K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Aghazadeh Behzad | Director, 10% Owner, See Remarks | Buy | 2,391,238 | $15.16 | $36,259,761.25 | +35.1% | |
| Jul 27, 2026 | Orbimed Advisors LLC66 | Director | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +286.7% | |
| Jul 27, 2026 | Ah Bio Fund Ii, L.P. | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +16.2% | |
| Jul 27, 2026 | Gordon Carl L74 | Director | Buy | 1,000,000 | $15.00 | $15,000,000.00 | +286.7% | |
| Jul 23, 2026 | Parrot David | Chief Financial Officer | Buy | 2,666 | $15.00 | $39,990.00 | New | |
| Jul 23, 2026 | Lucas Svetlana | Chief Business Officer | Buy | 3,000 | $15.00 | $45,000.00 | New |